NCT06987045View on ClinicalTrials.gov

Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

October 15, 2026

Study Completion Date

October 15, 2027

Conditions

Prostate CA

All Listed Sponsors

lead

Queen Mary University of London

OTHER

NCT06987045 - Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study | Biotech Hunter | Biotech Hunter